New Covenant Trust Company »

Sarepta Therapeutics shares owned by New Covenant Trust Company

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by New Covenant Trust Company from 13F filings

Historical chart of New Covenant Trust Company investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by New Covenant Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by New Covenant Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 249 129.46

More positions owned by New Covenant Trust Company

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard World Esg Us Stk Etf (ESGV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard World Esg Intl Stk Etf (VSGX)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Usa Esg Slc (SUSA)
Amazon (AMZN)
Fidelity Covington Trust Fundamental Larg (FFLC)
Vanguard Index Fds Sm Cp Val Etf (VBR)

View all positions for New Covenant Trust Company

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
Capital Research and Management Company - Division 3
venBio Select Advisor
State Street Corporation
Henderson Group
Wellington Management Company
Morgan Stanley
Farallon Capital Management
Bank of New York Mellon
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Susquehanna International

View all funds holding Sarepta Therapeutics